We are Prescient

We are a specialist, strategic partner to global biopharma companies, with the expertise and experience to bring value across the full drug life cycle from preclinical to loss of exclusivity and beyond. We partner with leading global biopharmaceutical companies, fast-growing mid-caps and cutting-edge emerging biotechs to unlock the full potential of their innovation to significantly improve people’s lives around the world.

Founded in 2007, we have developed into a highly diverse global business with a footprint in three continents. This diversity is our strength. Our team of over 500 is spread across thriving global hubs such as Boston, New Delhi, London, Beijing, Munich and Barcelona providing truly integrated global perspectives that allow us to see further and go deeper.

We build from a foundation of scientific knowledge and deep insights into molecule, market and customers. This intersection and application of market, competitor and customer perspectives is the foundation upon which our rigorous strategic thinking thrives.

Prescient has been a portfolio company of Bridgepoint Development Capital since 2021 and Baird Capital since 2017. For more information, please visit: www.prescienthg.com.